Publication | Closed Access

Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer

Radiation TherapyGastrointestinal OncologyMedicineKras MutationColorectal CancerPathologyRectal CancerNeoadjuvant Chemoradiation TherapyCancer TreatmentCancer GeneticsOncologyRadiation OncologyCancer Research